Mucolipidosis Type 4
What's New
Last Posted: Mar 04, 2023
- Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly.
Meloche Jolyane, et al. Molecular genetics & genomic medicine 2019 0 (1) e992 - [A novel compound heterozygous mutation of GNPTAB gene underlying a case with mucolipidosis type II ?/?].
Yang Ke, et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 0 (6) 606-609 - Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III.
Pasumarthi Divya, et al. Journal of human genetics 2020 0 (11) 971-984 - Shared facial phenotype of patients with mucolipidosis type IV: A clinical observation reaffirmed by next generation phenotyping.
Pode-Shakked Ben, et al. European journal of medical genetics 2020 0 (7) 103927 - Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
Frisch Amos, et al. Human genetics 2004 0 (4) 366-76 - Mucolipidosis type II and type III: a systematic review of 843 published cases.
Dogterom Emma J et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021 6 - A pilot study of gene testing of genetic bone dysplasia using targeted next-generation sequencing.
Zhang Huiwen, et al. Journal of human genetics 2015 9 - The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.
Gan-Or Ziv, et al. Neurology 2013 4 (17) 1606-10 - Mucolipidosis type 4
From NCATS Genetic and Rare Diseases Information Center - Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares Fuad, et al. Prenatal diagnosis 2008 3 (3) 236-41 - The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.
Bach Gideon, et al. Human mutation 2005 12 (6) 591 - Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
Edelmann Lisa, et al. American journal of human genetics 2002 4 (4) 1023-7 - Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.
Bargal R, et al. Human mutation 2001 5 (5) 397-402
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: